Top

Journal of Gastrointestinal Surgery

Published in:

01-11-2017 | Letter to the Editor

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Colorectal Cancer: Potential use of Perioperative Desmopressin to Reduce Allogenic Blood Transfusion Rates

Authors: Juan Garona, Natasha T. Sobol, Daniel F. Alonso

Published in: Journal of Gastrointestinal Surgery | Issue 11/2017

Excerpt

Dear Editors, …

Qiu L, Wang DR, Zhang XY, Gao S, Li XX, Sun GP and Lu XB. Impact of perioperative blood transfusion on immune function and prognosis in colorectal cancer patients. Transfus Apher Sci 2016; 54:235–241.CrossRefPubMed

Li L, Zhu D, Chen X, Huang Y, Ouyang M and Zhang W. Perioperative Allogenenic Blood Transfusion is Associated With Worse Clinical Outcome for Patients Undergoing Gastric Carcinoma Surgery: A Meta-Analysis. Medicine (Baltimore) 2015; 94:e1574.CrossRef

Bennett S, Baker LK, Martel G, Shorr R, Pawlik TM, Tinmouth A, McIsaac DI, Hebert PC, Karanicolas PJ, McIntyre L, Turgeon AF, Barkun J and Fergusson D. The impact of perioperative red blood cell transfusions in patients undergoing liver resection: a systematic review. HPB (Oxford) 2017; 19:321–330.CrossRef

Sutton JM, Kooby DA, Wilson GC, Squires MH, 3rd, Hanseman DJ, Maithel SK, Bentrem DJ, Weber SM, Cho CS, Winslow ER, Scoggins CR, Martin RC, 2nd, Kim HJ, Baker JJ, Merchant NB, Parikh AA, Abbott DE, Edwards MJ and Ahmad SA. Perioperative blood transfusion is associated with decreased survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma: a multi-institutional study. J Gastrointest Surg 2014; 18:1575–1587.CrossRefPubMed

Saxena A, Valle SJ, Liauw W and Morris DL. Allogenic Blood Transfusion Is an Independent Predictor of Poorer Peri-operative Outcomes and Reduced Long-Term Survival after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: a Review of 936 Cases. J Gastrointest Surg 2017; 21:1318–1327.CrossRefPubMed

Alonso DF, Ripoll GV, Garona J, Iannucci NB and Gomez DE. Metastasis: recent discoveries and novel perioperative treatment strategies with particular interest in the hemostatic compound desmopressin. Curr Pharm Biotechnol 2011; 12:1974–1980.CrossRefPubMedPubMedCentral

Ripoll GV, Garona J, Hermo GA, Gomez DE and Alonso DF. Effects of the synthetic vasopressin analog desmopressin in a mouse model of colon cancer. Anticancer Res 2010; 30:5049–5054.PubMed

Turner NA and Moake JL. Factor VIII Is Synthesized in Human Endothelial Cells, Packaged in Weibel-Palade Bodies and Secreted Bound to ULVWF Strings. PLoS One 2015; 10:e0140740.CrossRefPubMedPubMedCentral

Starke RD, Ferraro F, Paschalaki KE, Dryden NH, McKinnon TA, Sutton RE, Payne EM, Haskard DO, Hughes AD, Cutler DF, Laffan MA and Randi AM. Endothelial von Willebrand factor regulates angiogenesis. Blood 2011; 117:1071–1080.CrossRefPubMedPubMedCentral

10.

Mochizuki S, Soejima K, Shimoda M, Abe H, Sasaki A, Okano HJ, Okano H and Okada Y. Effect of ADAM28 on carcinoma cell metastasis by cleavage of von Willebrand factor. J Natl Cancer Inst 2012; 104:906–922.CrossRefPubMed

11.

Gragnano F, Sperlongano S, Golia E, Natale F, Bianchi R, Crisci M, Fimiani F, Pariggiano I, Diana V, Carbone A, Cesaro A, Concilio C, Limongelli G, Russo M and Calabro P. The Role of von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted Therapy. Mediators Inflamm 2017; 5620314.

12.

Giron S, Tejera AM, Ripoll GV, Gomez DE and Alonso DF. Desmopressin inhibits lung and lymph node metastasis in a mouse mammary carcinoma model of surgical manipulation. J Surg Oncol 2002; 81:38–44.CrossRefPubMed

13.

Ripoll GV, Garona J, Pifano M, Farina HG, Gomez DE and Alonso DF. Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model. Breast Cancer Res Treat 2013; 142:9–18.CrossRefPubMedPubMedCentral

14.

Weinberg RS, Grecco MO, Ferro GS, Seigelshifer DJ, Perroni NV, Terrier FJ, Sanchez-Luceros A, Maronna E, Sanchez-Marull R, Frahm I, Guthmann MD, Di Leo D, Spitzer E, Ciccia GN, Garona J, Pifano M, Torbidoni AV, Gomez DE, Ripoll GV, Gomez RE, Demarco IA and Alonso DF. A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-d-arginine vasopressin) in breast cancer patients. Springerplus 2015; 4:428.CrossRefPubMedPubMedCentral

15.

Saxena A, Chua TC, Fransi S, Liauw W and Morris DL. Effectiveness of early and aggressive administration of fresh frozen plasma to reduce massive blood transfusion during cytoreductive surgery. J Gastrointest Oncol 2013; 4:30–39.PubMedPubMedCentral

16.

Sargant N, Roy A, Simpson S, Chandrakumaran K, Alves S, Coakes J, Bell J, Knight J, Wilson P, Mohamed F, Cecil T and Moran B. A protocol for management of blood loss in surgical treatment of peritoneal malignancy by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Transfus Med 2016; 26:118–122.CrossRefPubMed

17.

Garona J, Pifano M, Scursoni AM, Gomez DE, Alonso DF and Ripoll GV. Insight into the effect of the vasopressin analog desmopressin on lung colonization by mammary carcinoma cells in BALB/c mice. Anticancer Res 2014; 34:4761–4765.PubMed

Title: Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Colorectal Cancer: Potential use of Perioperative Desmopressin to Reduce Allogenic Blood Transfusion Rates
Authors: Juan Garona
Natasha T. Sobol
Daniel F. Alonso
Publication date: 01-11-2017
Publisher: Springer US
Published in: Journal of Gastrointestinal Surgery / Issue 11/2017
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI: https://doi.org/10.1007/s11605-017-3551-6

ACC 2024 Congress

Springer Medicine

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Colorectal Cancer: Potential use of Perioperative Desmopressin to Reduce Allogenic Blood Transfusion Rates

Excerpt

ACC 2024 Congress

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 11/2017

Prognostic Significance of Surgical Margin Size After Neoadjuvant FOLFOX and/or FOLFIRI for Colorectal Liver Metastases

Early Recurrence of Neuroendocrine Liver Metastasis After Curative Hepatectomy: Risk Factors, Prognosis, and Treatment

Fasciola hepatica—a “Diver” in the Biliary Tree

Reply to Li et al. “Can Preoperative Frailty Accurately Predict Morbidity and Mortality Following Liver Surgery?”

Gallbladder Polypoid-Lesions: What Are They and How Should They be Treated? A Single-Center Experience Based on 1446 Cholecystectomy Patients

MR Imaging Features of Intestinal Phytobezoar